Pancreatic Cancer Awareness Month – Together for New Therapies

Pancreatic cancer is the seventh deadliest form of cancer. It is considered to be one of the most difficult cancers to treat due to its insidious symptoms and high degree of malignancy, leading to a high mortality rate.
In line with our ambitions #Servier2030, the fight against cancer is one of our strategic priorities. We are committed to advancing the treatment of malignancies that have limited therapeutic options.
We are further strengthening our ecosystem through further research within our monoclonal antibody development center in Denmark, Simphogen and the research and development center in the U.S., with a major focus on the development of innovative antitumor therapies.